At the news
? NEUTRALIMPACT 2/10 6-K filed Aug 3, 2026 at 10:44 ET
AstraZeneca filed a routine 6-K notification of admission of 8,855 ordinary shares under its employee share schemes, issued between 1 July and 31 July 2026 under a block admission from January 2021. The total shares outstanding increased to 1,551,033,389, representing negligible dilution of ~0.00057%. This is an administrative filing with no material impact on the company's financials or stock price.
- AstraZeneca admitted 8,855 ordinary shares under employee share schemes
- Total shares outstanding after admission: 1,551,033,389
- Issued between 1 July 2026 and 31 July 2026 under block admission dated 29 January 2021
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access